Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
NCT02607683
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Steatoblepharon
Interventions
DRUG:
XAF5 (concentration A: 0.1%)
DRUG:
XAF5 (concentration B: 0.035%)
DRUG:
Matching placebo
Sponsor
Topokine Therapeutics, Inc.